Clinical trial · Interventional
A Pilot Study of a Home-Based Walking Intervention for Pancreatic Cancer Patients
NCT02442323CI-TRIAL-00049229completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Despite evidence regarding the benefits of physical activity in various cancer patient populations, the effects of a home-based walking program for pancreatic cancer patients have been under-explored. The aims of the proposed pilot project are to: (1) Assess the feasibility of implementing a 12-week, home-based walking program among pancreatic cancer patients; and (2) Examine the effects of a 12-week, home-based walking program on quality of life (QOL) and symptoms among pancreatic cancer patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Pancreas | Malignant Pancreatic Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Walking Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Walking Intervention
- description
- Intervention patients will receive a 12-week home-based walking program, which includes a personalized instruction booklet and pedometer. The walking program consists of 3 phases and will be individualized for each patient based on their physical condition and baseline assessment. Patients are instructed to walk 3 to 5 times each week at home or other safe environment. Patients will be instructed on a gradual increase in walking time over the course of the intervention.
- interventionNames
- Behavioral: Walking Intervention
- type
- NO_INTERVENTION
- label
- Usual Care
- description
- Usual care patients will receive standard of care. They will not receive any instruction on walking or other physical activity other than what is normally provided by their physician or clinical staff.
Primary outcomes (1)
- measure
- Patient-reported outcome of quality of life
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients aged 18 years or older * Have histologically confirmed adenocarcinoma of the pancreas (including adenocarcinoma subtypes such as signet ring carcinoma, adenosquamous carcinoma, undifferentiated/poorly differentiated carcinoma, and mucinous carcinoma) * Have an estimated life expectancy of greater than 3 months * Have an Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1, or 2 * Are undergoing treatment for pancreatic cancer at Fox Chase Cancer Center * Have borderline resectable or unresectable locally advanced disease or metastatic disease Exclusion Criteria: * Patients with islet cell/neuroendocrine or papillary cystic neoplasm * Patients scheduled to undergo surgical resection for curative intent during study participation * Patients receiving 3rd-line palliative chemotherapy * Inability to communicate in English.
References
Publications (0)
Data not yet available
No reference posted for this study.